Literature DB >> 27201337

Cost Consequence Analysis Of Darbepoetin Alfa For The Treatment Of Anemia Due To Chronic Kidney Disease (Ckd) In Greece.

G Kourlaba1, I Boletis2, D Goumenos3, C Iatrou4, V Papagiannopoulou5, G Tritaki5, N Maniadakis6.   

Abstract

Entities:  

Year:  2014        PMID： 27201337     DOI： 10.1016/j.jval.2014.08.1323

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  1 in total

1.  Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure: A randomized, open-label, parallel-group, non-inferiority Phase III trail.

Authors:  Nan Chen; Changying Xing; Jianying Niu; Bicheng Liu; Junzhou Fu; Jiuyang Zhao; Zhaohui Ni; Mei Wang; Wenhu Liu; Jinghong Zhao; Ling Zhong; Xiongfei Wu; Wenge Li; Yuqing Chen; Wei Shi; Jianghua Chen; Aiping Yin; Ping Fu; Rong Wang; Gengru Jiang; Fanfan Hou; Guohua Ding; Jing Chen; Gang Xu; Yuichiro Kondo; Yuliang Su; Changlin Mei
Journal:  Chronic Dis Transl Med       Date:  2022-03-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.